Hyphens Pharma International Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was SGD 74.71 million compared to SGD 80.7 million a year ago. Net income was SGD 3.57 million compared to SGD 6.16 million a year ago.

Basic earnings per share from continuing operations was SGD 0.0115 compared to SGD 0.02 a year ago. Diluted earnings per share from continuing operations was SGD 0.0115 compared to SGD 0.0199 a year ago.